English
Aarti Pharmalabs Q4 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
768.15
7.80 (1.03%)
7.80 (1.03%)Volume99.70 K
Updated: Fri 23 Jan, 2026 | 15:25:50
NSE
770.059.90 (1.30%)
9.90 (1.30%)Volume2.23 L
Updated: Fri 23 Jan, 2026 | 15:25:51
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Aarti Pharmalabs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 440.97 | 432.21 | 2.03% | 407.38 | 8.25% |
| Depreciation/ Amortization | 22.82 | 23.04 | -0.96% | 19.13 | 19.30% |
| Operating Income | 122.81 | 105.57 | 16.33% | 98.39 | 24.82% |
| Net Income | 88.34 | 73.99 | 19.40% | 65.25 | 35.38% |
| Other Operating Expenses Total | 0.00 | 92.23 | 0.00% | 0.00 | 0.00% |
| Net Income Before Taxes | 114.62 | 100.63 | 13.91% | 95.75 | 19.70% |
| Total Revenue | 563.78 | 537.78 | 4.83% | 505.77 | 11.47% |
| Selling/ General/ Admin Expenses Total | 139.40 | 41.63 | 234.85% | 135.14 | 3.16% |
| Diluted Normalized EPS | 9.75 | 8.16 | 19.48% | 7.20 | 35.34% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.